Accenture

ACN · NYSE

$239.12+$2.19 (+0.92%)TodayMarket closed ·
Prev close $236.93

ACN analyst rating

BuyConsensus of 22 analysts over the last 12 months. 50% rate it a buy.
  • Strong buy0
  • Buy11
  • Hold11
  • Underperform0
  • Sell0

12-month price target · 27 analysts

Average $212.20 (−11.3% downside)

Low
$151.50
Now
$239.12
High
$345.45

Upgrades and downgrades

The latest rating actions, newest first

ACN analyst upgrades, downgrades and rating actions
FirmDateActionRating
TD CowenOct 15, 2026MaintainsHold
SusquehannaOct 15, 2026MaintainsNeutral
MizuhoOct 6, 2026MaintainsOutperform
Goldman SachsOct 2, 2026MaintainsBuy
Truist SecuritiesOct 2, 2026MaintainsHold
Wells FargoOct 2, 2026MaintainsEqual-Weight
TD CowenOct 2, 2026MaintainsHold
RBC CapitalOct 2, 2026MaintainsOutperform
Evercore ISI GroupOct 2, 2026MaintainsOutperform
GuggenheimOct 2, 2026MaintainsNeutral

The case for and against

Updated Oct 14, 2026

Bull case

Accenture is supported by durable demand visibility, as 4Q26 bookings rose to $22.2B with a 1.2x book-to-bill, including $12.8B in Managed Services at 1.4x, while revenue grew 7% in local currency and EPS reached $3.29. Its positive outlook is reinforced by share gains in tech-managed services, over 400 net-new AI client initiations in FY26, and a strategic push into AI safety through the Anthropic partnership and a $1B five-year investment. Financially, the company also generated $2.8B of FCF in 4Q26, returned a record $11.5B to shareholders in FY26, and guided FY27 revenue growth of 3% to 6% with 10 to 30 bps of margin expansion and EPS of $14.39 to $14.81.

Bear case

Accenture is facing a weakening fundamental backdrop as macroeconomic slowdown, especially in North America and Europe, threatens discretionary IT spending, delays deal flow, and softens revenue growth in its core consulting markets. Competitive intensity in the fragmented IT services industry is likely to pressure margins through pricing compression, while wage inflation and stock-based compensation can erode profitability and dilute shareholders. Although the firm retains scale and historically solid financial strength, FY27 free cash flow guidance of $11.0B-$11.8B implies declining FCF year over year at the midpoint, and added LT debt, FX risk, and AI-related narrative headwinds leave limited catalysts for recovery.

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.